NDC 63629-8511-01 - Naproxen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-8511
- Requested NDC
- 63629-8511-01
- Package NDCs from labels
- 63629-8511-1, 63629-8511-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-04-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-04-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-8511-1 | Naproxen | 500 in 1 BOTTLE | TABLET | 500 | 105 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-8511 | NAPROXEN TABLET [BRYANT RANCH PREPACK] | 104 | Current NDC, Legacy NDC, 1 package rows | 20240418_f18181f4-6b14-48a8-a149-e45b3360a250.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-8511-1 | EA - Each | 63629-8511 | fcee8a03-3f98-44e0-bc20-79829c74f86c | 1 | 2021-07-15 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen | NAPROXEN | Bryant Ranch Prepack | 124af155-0661-4054-9800-de547d8212d7 | 2025-09-17 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Eyes Irritation Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | CARDINAL HEALTH 110, LLC. DBA LEADER | bd2608c6-ffdf-352a-e053-2995a90a26a8 | 2025-09-12 | Warnings | FZ989GH94E |
| Naproxen | NAPROXEN | Zameer Pharmaceuticals LLC | d2e5553a-7c90-407c-9f07-3be65560c23a | 2025-08-23 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen and esomeprazole magnesium | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | PHOENIX RX LLC | 3a652450-525b-4839-e063-6294a90ac287 | 2025-08-14 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen and esomeprazole magnesium | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | Preferred Pharmaceuticals Inc | 470496f5-a71d-40b2-bf11-3a8d3d790962 | 2025-07-31 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen and esomeprazole magnesium | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | PHOENIX RX LLC | 3a6637ca-0c55-f648-e063-6294a90aaef7 | 2025-07-20 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | 29d98cf3-a0f2-3f89-e054-00144ff88e88 | 2025-07-15 | Boxed warning, Warnings, Adverse reactions | 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | Proficient Rx LP | e64b3b36-f96e-463e-aca8-8f6e86724bcf | 2025-07-01 | Boxed warning, Warnings, Adverse reactions | ANDA212517 198013 57Y76R9ATQ |
| Naproxen | NAPROXEN | Aurobindo Pharma Limited | 0e5315bc-c02f-4749-be69-b5b528327d58 | 2025-06-07 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | Amneal Pharmaceuticals LLC | c43a43e2-e867-448d-8f59-3efc7c077cbc | 2025-05-28 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | A-S Medication Solutions | 7fef9311-471b-472c-b4f2-c952a2b3a255 | 2025-05-07 | Boxed warning, Warnings, Adverse reactions | ANDA212517 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | Camber Pharmaceuticals, Inc. | fd5e8d84-f92c-4f4b-ab0d-4cda7cf826bd | 2025-05-06 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | Coupler LLC | 3375e139-d9de-8c2d-e063-6394a90a653d | 2025-04-23 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | A-S Medication Solutions | e63a034d-23ef-458f-88ed-8b6d73699621 | 2025-04-17 | Boxed warning, Warnings, Adverse reactions | 198013 57Y76R9ATQ |
| Naproxen | NAPROXEN | Asclemed USA, Inc. | 1e406e47-408a-48cc-921e-52882a11581c | 2025-04-11 | Boxed warning, Warnings, Adverse reactions | ANDA212517 198014 57Y76R9ATQ |
| Naproxen Oral Suspension | NAPROXEN ORAL | ANI Pharmaceuticals, Inc. | 252726a7-757a-4b97-b5b8-ffff4ac1d103 | 2025-03-25 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | Bryant Ranch Prepack | 9d7bc470-fbba-40a6-a56c-f681a3cee9cf | 2025-03-24 | Boxed warning, Warnings, Adverse reactions | 198014 57Y76R9ATQ |
| Naproxen | NAPROXEN | Preferred Pharmaceuticals Inc. | 727913f6-9542-4a2d-9318-4b7ff521bffd | 2025-03-20 | Boxed warning, Warnings, Adverse reactions | 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | Amneal Pharmaceuticals of New York LLC | 2718e0b7-1ce6-457e-bee9-11b634dfd353 | 2025-03-18 | Boxed warning, Warnings, Adverse reactions | 198014 198013 198012 57Y76R9ATQ |
| Naproxen | NAPROXEN | ANI Pharmaceuticals, Inc. | 052e6fe3-d619-42c3-b64e-67c7aaf7271c | 2025-03-12 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.